Published in Int J Radiat Oncol Biol Phys on October 12, 1982
Anti-Inflammatory Agents for Cancer Therapy. Mol Cell Pharmacol (2009) 0.98
The role of dexamethasone in the modification of misonidazole pharmacokinetics. Br J Cancer (1983) 0.75
Dexamethasone and radiation response in the Lewis lung tumour model. Br J Cancer (1983) 0.75
The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med (2000) 5.72
Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol (2004) 4.46
Metabolic modulation of glioblastoma with dichloroacetate. Sci Transl Med (2010) 3.99
Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem (2000) 3.30
Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells. Circ Res (2000) 3.12
Clinical phase I study of the hypoxic cell radiosensitizer RO-07-0582, a 2-nitroimidazole derivative. Radiology (1977) 2.55
Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res (2000) 2.39
Enhanced electron flux and reduced calmodulin dissociation may explain "calcium-independent" eNOS activation by phosphorylation. J Biol Chem (2000) 2.10
Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood (2001) 1.98
Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1994) 1.96
Phase 1 study of high-dose metronidazole: a specific in vivo and in vitro radiosensitizer of hypoxic cells. Radiology (1975) 1.90
Letter: "High-dose" metronidazole: a preliminary pharmacological study prior to its investigational use in clinical radiotherapy trials. Br J Radiol (1974) 1.87
Acute otitis media caused by Branhamella catarrhalis: biology and therapy. Rev Infect Dis (1987) 1.77
A randomized controlled trial of amoxicillin plus clavulanate compared with cefaclor for treatment of acute otitis media. J Pediatr (1986) 1.72
Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem (2001) 1.65
Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis. Am J Pathol (1999) 1.58
Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest (2000) 1.56
Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol (1999) 1.52
Characterization of T cell repertoire changes in acute Kawasaki disease. J Exp Med (1993) 1.51
Identification of novel CHD1-associated collaborative alterations of genomic structure and functional assessment of CHD1 in prostate cancer. Oncogene (2011) 1.50
The management and clinical course of testicular seminoma: 15 years' experience at a single institution. Clin Oncol (R Coll Radiol) (1998) 1.43
Peripheral neuropathy related to misonidazole: incidence and pathology. Br J Cancer Suppl (1978) 1.42
Splenectomy during partial remission in thrombotic thrombocytopenic purpura with prolonged plasma exchange dependency. Am J Hematol (1999) 1.41
Effect of radiation on cytokine and cytokine receptor messenger-RNA profiles in p53 wild and mutated human glioblastoma cell lines. Clin Invest Med (2001) 1.41
Fraud and abuse revisited. Current schemes and scams in Florida. J Fla Med Assoc (1994) 1.38
Baculovirus expression and antigenic characterization of the capsid proteins of three Norwalk-like viruses. Arch Virol (2002) 1.34
Binding of 3H-misonidazole to solid human tumors as a measure of tumor hypoxia. Int J Radiat Oncol Biol Phys (1986) 1.32
The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol (1978) 1.31
Acidic hydrolysis as a mechanism for the cleavage of the Glu(298)-->Asp variant of human endothelial nitric-oxide synthase. J Biol Chem (2001) 1.27
Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine. Br J Cancer (2001) 1.26
Distribution and severity of weakness among patients with polymyositis, dermatomyositis and juvenile dermatomyositis. Rheumatology (Oxford) (2008) 1.26
Canadian recommendations for the treatment of glioblastoma multiforme. Curr Oncol (2007) 1.24
Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane. Blood (1999) 1.23
A novel technique for measuring human tissue pO2 at the cellular level. Br J Cancer (1986) 1.21
Temporal events underlying arterial remodeling after chronic flow reduction in mice: correlation of structural changes with a deficit in basal nitric oxide synthesis. Circ Res (2000) 1.16
Long-term glioblastoma multiforme survivors: a population-based study. Can J Neurol Sci (1998) 1.15
Surgery in Kurdistan. Ann R Coll Surg Engl (1977) 1.14
Specificity of starch synthase isoforms from potato. Eur J Biochem (1999) 1.14
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol (1980) 1.12
Absence of IFNA and IFNB genes from human malignant glioma cell lines and lack of correlation with cellular sensitivity to interferons. Cancer Res (1990) 1.11
Stimulation of [3H]thymidine uptake in mouse marrow by granulocyte-macrophage colony stimulating factor from mouse lung conditioned medium. J Immunol Methods (1983) 1.10
Single-arm, open-label phase II study of intravenously administered tirapazamine and radiation therapy for glioblastoma multiforme. J Clin Oncol (2000) 1.09
Radiobiological characterization of the inactivating events produced in mammalian cells by helium and heavy ions. Int J Radiat Oncol Biol Phys (1977) 1.08
Renal cytochrome P450 omega-hydroxylase and epoxygenase activity are differentially modified by nitric oxide and sodium chloride. J Clin Invest (1999) 1.08
Enzyme-bound conformations of nucleotide substrates. X-ray structure and absolute configuration of 8,5'-cycloadenosine monohydrate. Biochemistry (1980) 1.07
Hyperpolarizing factors. Biochem Pharmacol (1997) 1.06
Canadian recommendations for the treatment of recurrent or progressive glioblastoma multiforme. Curr Oncol (2011) 1.06
Matrix metalloproteinase and tissue inhibitors of metalloproteinase secretion by haematopoietic and stromal precursors and their production in normal and leukaemic long-term marrow cultures. Br J Haematol (2001) 1.05
Bcr-abl-positive cells secrete angiogenic factors including matrix metalloproteinases and stimulate angiogenesis in vivo in Matrigel implants. Leukemia (2002) 1.04
Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis. Bone Marrow Transplant (2002) 1.02
Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J Biol Response Mod (1986) 0.99
A phase I trial of 1,3-bis(2-chloroethyl)-1-nitrosourea plus temozolomide: a North American Brain Tumor Consortium study. Neuro Oncol (2000) 0.99
Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br J Haematol (1999) 0.99
Monoclonal antibodies against human granulocytes and myeloid differentiation antigens. Hum Immunol (1982) 0.97
Non-invasive assessment of human tumour hypoxia with 123I-iodoazomycin arabinoside: preliminary report of a clinical study. Br J Cancer (1992) 0.97
The cost of radiotherapy at an Ontario regional cancer centre: a re-evaluation. Crit Rev Oncol Hematol (1999) 0.96
Delayed post-traumatic rupture of the bladder. J R Coll Surg Edinb (1974) 0.96
Cystic medial necrosis in coarctation of the aorta: a potential factor contributing to adverse consequences observed after percutaneous balloon angioplasty of coarctation sites. Circulation (1987) 0.95
Leiomyosarcoma of the inferior vena cava. Clin Oncol (1978) 0.95
Physical exercise and quality of life in cancer patients following high dose chemotherapy and autologous bone marrow transplantation. Psychooncology (2000) 0.95
Induction of the expression of HLA class I antigens on K562 by interferons and sodium butyrate. Hum Immunol (1985) 0.94
Imaging tumor hypoxia and tumor perfusion. J Nucl Med (1993) 0.94
Demonstration of functional cytokine-placental interactions: CSF-1 and GM-CSF stimulate human cytotrophoblast differentiation and peptide hormone secretion. Exp Cell Res (1994) 0.94
Reassessment of the classification of the Order Haplosclerida (Class Demospongiae, Phylum Porifera) using 18S rRNA gene sequence data. Mol Phylogenet Evol (2006) 0.93
Radiotherapy pilot trials with sensitizers of hypoxic cells: metronidazole in supratentorial glioblastomas. Br J Radiol (1977) 0.93
Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque. Stroke (2001) 0.93
Voltage-operated Ca(2+) and Na(+) channels in the oligodendrocyte lineage. J Neurosci Res (2009) 0.93
On the use of lonafarnib in myelodysplastic syndrome and chronic myelomonocytic leukemia. Leukemia (2008) 0.92
Synergistic stimulation of macrophage proliferation by the monokines tumor necrosis factor-alpha and colony-stimulating factor 1. Blood (1989) 0.92
American Thoracic Society. Medical Section of the American Lung Association. Guidelines for short-course tuberculosis chemotherapy. Am Rev Respir Dis (1980) 0.92
The application in radiation therapy of substances which modify cellular radiation response. Cancer (1977) 0.91
Phase II study of paclitaxel in patients with recurrent malignant glioma. J Clin Oncol (1996) 0.91
Phenotypic characterization of the human fibrous histiocytoma giant cell tumor (GCT) cell line and its cytokine repertoire. Exp Hematol (1993) 0.90
Radiosensitivity testing of human primary brain tumor specimens. Int J Radiat Oncol Biol Phys (1992) 0.90
Diffusion limited hypoxia estimated by vascular image analysis: comparison with pimonidazole staining in human tumors. Radiother Oncol (2000) 0.89
Contribution of calcium-activated potassium channels to the vasodilator effect of bradykinin in the isolated, perfused kidney of the rat. Br J Pharmacol (1996) 0.89
Prognostic significance of serial magnetic resonance spectroscopies over the course of radiation therapy for patients with malignant glioma. Clin Invest Med (2006) 0.88
Phase I study of corynebacterium parvum in patients with solid tumors. Cancer Chemother Rep (1976) 0.88
Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol) (2010) 0.88
Comparison of prognostic factors and survival among black patients and white patients treated with irradiation for non-small-cell lung cancer. J Natl Cancer Inst (1992) 0.87
Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03. Int J Radiat Oncol Biol Phys (1990) 0.87
Multiple daily fractionated radiation therapy and misonidazole in the management of malignant astrocytoma. A preliminary report. Cancer (1985) 0.86
Microcomputer interface for rapid measurements of average volume using an electronic particle counter. Med Biol Eng Comput (1982) 0.86
Identification of a hypoxic population of bone marrow cells. Int J Radiat Oncol Biol Phys (1983) 0.86
Misonidazole combined with hyperfractionation in the management of malignant glioma. Int J Radiat Oncol Biol Phys (1984) 0.86
NCIC-CTG phase II study of gemcitabine in patients with malignant glioma (IND.94). Ann Oncol (2000) 0.85
Alveolar soft-part sarcoma presenting with eosinophilia and shunt. Can Respir J (2005) 0.85
Vinblastine, bleomycin, and cisplatin in malignant germ cell tumors of the ovary. Cancer (1985) 0.85
Radiation and nitroimidazoles in supratentorial high grade gliomas: a second clinical trial. Br J Cancer (1982) 0.85
Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol (1998) 0.84
NO-independent vasodilation to acetylcholine in the rat isolated kidney utilizes a charybdotoxin-sensitive, intermediate-conductance Ca(++)-activated K+ channel. J Pharmacol Exp Ther (1998) 0.84
Relationship between the neurotoxicity of the hypoxic cell radiosensitizer SR 2508 and the pharmacokinetic profile. Cancer Res (1987) 0.84
Hyperfractionated radiation therapy for brain-stem glioma: a phase I-II trial. J Neurosurg (1989) 0.84